INSULIN-ANTIBODIES AND INSULIN AUTOANTIBODIES

[81] Bonifacio E., Bingley PJ, Shattock M., Et al., Quantification of islet‐cell antibodies and prediction of insulin‐dependent diabetes, Lancet, 335, pp. 147-149, (1990)

[82] Johnston C., Millward BA, Hoskins P., Leslie RDG, Bottazzo GF, Pyke DA, Islet cell antibodies as predictors of the later development of type I (insulin‐dependent) diabetes, Diabetologia, 32, pp. 382-386, (1989)

[83] Millward BA, Alvissi L., Hoskins PJ, Et al., Immune changes associated with insulin dependent diabetes may remit without causing the disease: a study in identical twins, Br Med J, 292, pp. 793-796, (1986)

[84] Ziegler AG, Vardi P., Ricker AT, Hattori M., Soeldner JS, Eisenbarth GS, Radioassay determination of insulin autoantibodies in NOD mice. Correlation with increased risk of progression to overt diabetes, Diabetes, 38, pp. 358-363, (1989)

[85] Soeldner JS, Tuttleman M., Srikanta S., Ganda OP, Eisenbarth SG, Insulin‐dependent diabetes mellitus and autoimmunity: islet‐cell autoantibodies, insulin autoantibodies, and beta cell failure, N Engl J Med, 313, pp. 893-894, (1985)

[86] Betterle C., Presotto F., Pedini B., Et al., Islet cell and insulin autoantibodies in organ‐specific autoimmune patients. Their behaviour and predictive value for the development of type I (insulin‐dependent) diabetes mellitus. A 10‐year follow‐up study, Diabetologia, 30, pp. 292-297, (1987)

[87] Bergua M., Sole J., Marion G., Et al., Prevalence of islet cell antibodies, insulin antibodies and hyperglycaemia in 2291 school children, Diabetologia, 30, pp. 724-726, (1987)

[88] Srikanta S., Ricker AT, McCulloch DK, Soeldner JS, Eisenbarth GS, Palmer JP, Autoimmunity to insulin, beta cell dysfunction, and development of insulin‐dependent diabetes mellitus, Diabetes, 35, pp. 139-142, (1986)

[89] Dean BM, Becker F., McNally JM, Et al., Insulin autoantibodies in the prediabetic period. Correlation with islet cell antibodies and development of diabetes, Diabetologia, 29, pp. 339-342, (1986)

[90] Ziegler AG, Ziegler R., Jackson RA, Eisenbarth GS, Testing the linear destruction hypothesis in Type I diabetes: The Joslin Study, Immunotherapy of Type I Diabetes, pp. 155-167, (1989)

[81] Bonifacio E., Bingley PJ, Shattock M., Et al., Quantification of islet‐cell antibodies and prediction of insulin‐dependent diabetes, Lancet, 335, pp. 147-149, (1990)

[82] Johnston C., Millward BA, Hoskins P., Leslie RDG, Bottazzo GF, Pyke DA, Islet cell antibodies as predictors of the later development of type I (insulin‐dependent) diabetes, Diabetologia, 32, pp. 382-386, (1989)

[83] Millward BA, Alvissi L., Hoskins PJ, Et al., Immune changes associated with insulin dependent diabetes may remit without causing the disease: a study in identical twins, Br Med J, 292, pp. 793-796, (1986)

[84] Ziegler AG, Vardi P., Ricker AT, Hattori M., Soeldner JS, Eisenbarth GS, Radioassay determination of insulin autoantibodies in NOD mice. Correlation with increased risk of progression to overt diabetes, Diabetes, 38, pp. 358-363, (1989)

[85] Soeldner JS, Tuttleman M., Srikanta S., Ganda OP, Eisenbarth SG, Insulin‐dependent diabetes mellitus and autoimmunity: islet‐cell autoantibodies, insulin autoantibodies, and beta cell failure, N Engl J Med, 313, pp. 893-894, (1985)

[86] Betterle C., Presotto F., Pedini B., Et al., Islet cell and insulin autoantibodies in organ‐specific autoimmune patients. Their behaviour and predictive value for the development of type I (insulin‐dependent) diabetes mellitus. A 10‐year follow‐up study, Diabetologia, 30, pp. 292-297, (1987)

[87] Bergua M., Sole J., Marion G., Et al., Prevalence of islet cell antibodies, insulin antibodies and hyperglycaemia in 2291 school children, Diabetologia, 30, pp. 724-726, (1987)

[88] Srikanta S., Ricker AT, McCulloch DK, Soeldner JS, Eisenbarth GS, Palmer JP, Autoimmunity to insulin, beta cell dysfunction, and development of insulin‐dependent diabetes mellitus, Diabetes, 35, pp. 139-142, (1986)

[89] Dean BM, Becker F., McNally JM, Et al., Insulin autoantibodies in the prediabetic period. Correlation with islet cell antibodies and development of diabetes, Diabetologia, 29, pp. 339-342, (1986)

[90] Ziegler AG, Ziegler R., Jackson RA, Eisenbarth GS, Testing the linear destruction hypothesis in Type I diabetes: The Joslin Study, Immunotherapy of Type I Diabetes, pp. 155-167, (1989)